Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT-KO-003 in Relapsing Remitting Multiple Sclerosis
NCT01428726Phase 2Completed
- Sponsor
- Neurotech Pharmaceuticals
- Start
- Jun 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of diazoxide in relapsing-remitting multiple sclerosis (RRMS), sponsored by Neurotech Pharmaceuticals. Started Jun 2011; status: completed.
02
Drugs
diazoxide
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01428726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01428726.